Tushar Mungle, Ananya Mahadevan, Parag Das, Amit K Mehta, Manash P Gogoi, Bishwaranjan Jana, Niharendu Ghara, Debjani Ghosh, Vaskar Saha, Shekhar Krishnan
Acute lymphoblastic leukemia treatment includes an outpatient (OP)-based 2-year maintenance therapy (MT). Over an 8-year period, patients were transited from only OP to a hybrid e-clinic/OP-clinic model. Electronic and patient-held medical records of acute lymphoblastic leukemia patients 1 to 18 years old during MT were used to analyze demographics, drug doses, treatment response and cost. A survey evaluated family satisfaction with the hybrid service. Four hundred and seventy-eight children, all with at least 1 year of MT from March 13, 2014 to March 24, 2022 were grouped into 4 treatment eras, representing the transition from all OP (era 1) to the current hybrid MT practice (era 4)...
January 1, 2024: Journal of Pediatric Hematology/oncology